
    
      Small Intestinal neuroendocrine patients, with a positive Ga-68-DOTATOC PET/CT, will receive
      a small amount of beta- radiopharmaceutical (Y-90-DOTATOC), and then operated, as clinical
      indicated.

      Tissue samples will be tested ex-vivo with a beta-probe prototype
    
  